PBH

시간 외 거래: 65.40 -0.18 -0.27%

Prestige Consumer Healthcare Inc (PBH)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Prestige Consumer Healthcare Inc Stock (PBH) Company Profile

Prestige Consumer Healthcare Inc

Healthcare (1163)

(914) 524-6800

660 WHITE PLAINS RD., TARRYTOWN, NY

최신 SEC 제출 서류

PBH's Discussions on Twitter

PBH을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
PBH Prestige Consumer Healthcare Inc	65.58	3.70B	1.11B	205.95M	254.64M	4.11
ZTS Zoetis Inc	147.35	64.93B	9.39B	2.61B	2.22B	5.81
TAK Takeda Pharmaceutical Co Adr	14.44	45.07B	29.98B	958.27M	5.31B	0.2964
HLN Haleon Plc Adr	9.54	41.53B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	16.37	18.37B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	301.50	13.68B	2.99B	1.21B	1.13B	25.06

Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-12-09	다운그레이드	Sidoti	Buy → Neutral
2024-06-21	업그레이드	DA Davidson	Neutral → Buy
2022-11-17	개시	Canaccord Genuity	Buy
2022-05-10	업그레이드	Jefferies	Hold → Buy
2022-05-09	업그레이드	Oppenheimer	Perform → Outperform
2020-08-07	다운그레이드	DA Davidson	Buy → Neutral
2020-06-29	업그레이드	Sidoti	Neutral → Buy
2020-04-14	다운그레이드	Jefferies	Buy → Hold
2020-04-07	재개	Sidoti	Neutral
2020-03-26	업그레이드	Jefferies	Hold → Buy
2020-03-24	개시	Oppenheimer	Perform
2020-03-19	업그레이드	DA Davidson	Neutral → Buy
2019-01-15	다운그레이드	Raymond James	Outperform → Mkt Perform
2017-12-04	업그레이드	William Blair	Mkt Perform → Outperform
2017-06-02	업그레이드	Jefferies	Underperform → Hold
2017-05-22	업그레이드	Raymond James	Mkt Perform → Outperform
2016-12-27	재확인	B. Riley & Co.	Buy
2016-11-17	개시	Gabelli & Co	Buy
2016-08-12	업그레이드	Sidoti	Neutral → Buy
2016-03-08	개시	KeyBanc Capital Mkts	Overweight
2016-02-05	개시	Piper Jaffray	Overweight
2015-11-30	다운그레이드	Jefferies	Hold → Underperform
2014-04-28	재확인	B. Riley & Co.	Buy
2014-04-28	재확인	Oppenheimer	Outperform
2013-07-09	개시	B. Riley & Co.	Buy

Prestige Consumer Healthcare Inc 주식(PBH)의 최신 뉴스

Prestige Consumer Healthcare Inc (PBH) 재무 분석

Prestige Consumer Healthcare Inc (PBH)

Prestige Consumer Healthcare Inc Stock (PBH) Company Profile

PBH을(를) 다른 주식과 비교

Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades

Prestige Consumer Healthcare Inc 주식(PBH)의 최신 뉴스

Prestige Consumer Healthcare's Strategic Acquisition and Q1 Earnings: A Value Investment Case in a Resilient OTC Sector - AInvest

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its First-Quarter Earnings: Here's What Analysts Think - ca.finance.yahoo.com

Prestige Consumer Healthcare Acquires Pillar5 Pharma for Expansion - MSN

Prestige Consumer Healthcare Inc. (NYSE:PBH) Q1 2026 Earnings Call Transcript - Insider Monkey

Prestige Consumer Starting Clear Eyes Production With No Contract Partner ‘Out There To Tap Into’ - insights.citeline.com

Prestige Consumer Healthcare's Q1 2026: Key Contradictions in Clear Eyes Supply, Market Share, and Margin Outlook - AInvest

Prestige Consumer Healthcare stock hits 52-week low at 64.83 USD By Investing.com - Investing.com South Africa

Prestige Consumer Healthcare stock hits 52-week low at 64.83 USD - Investing.com Nigeria

Prestige Brands stock price target lowered to $100 at Canaccord on eye care supply issues - Investing.com Australia

Prestige Consumer Healthcare's Strategic Path to Recovery: Can Shareholders Capitalize on a Turnaround in Eye Care and Margin Expansion? - AInvest

Prestige Consumer Healthcare: Fiscal Q1 Earnings Snapshot - Manistee News Advocate

Prestige Consumer Healthcare: Strategic Acquisitions and Innovation Drive Long-Term Value Creation - AInvest

Prestige Consumer Healthcare outlines $1.1B-$1.115B FY26 revenue target amid Pillar5 acquisition and Clear Eyes supply recovery - MSN

Prestige Consumer Healthcare Q1 Earnings and Strategic Acquisition of Pillar5 Pharma - AInvest

Prestige Consumer Healthcare’s Q1 Earnings and Strategic Moves - TipRanks

Prestige Consumer Healthcare Q1 2026 Earnings Call Transcript - MarketBeat

Prestige Consumer Healthcare shares fall 10.14% intraday after missing Q1 revenue estimates and lowering fiscal 2026 outlook. - AInvest

Prestige Consumer Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Prestige Consumer Healthcare Inc. Q1 Profit Decreases, Misses Estimates - Nasdaq

Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Prestige Consumer Healthcare's Strategic Acquisition of Anjac SAS: A Catalyst for OTC Men's Health Dominance - AInvest

Prestige Consumer Healthcare Eyes Growth Despite Revenue Shortfall - Finimize

Prestige Consumer Healthcare on Aug 4, unit entered agreement with Anjac SASSEC filing - MarketScreener

Prestige Consumer Healthcare Q1 FY26 slides: Revenue drops on supply issues, margins improve - Investing.com India

Prestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue Estimates - Yahoo Finance

Prestige Consumer Healthcare Q1 Revenue Falls 6.6% Amid Supply Constraints and Order Timing Shifts - AInvest

Prestige Consumer Healthcare's Strategic Acquisition of Pillar5 Pharma: A Masterstroke in Supply Chain Resilience and Competitive Edge - AInvest

Prestige Consumer Healthcare Reports Lower Q1 Earnings Than ExpectedNews and Statistics - IndexBox

Prestige Consumer's Strategic Turnaround: Assessing Brand Resilience and M&A-Driven Growth in a High-Margin Sector - AInvest

Prestige Consumer Healthcare Inc. SEC 10-Q Report - TradingView

Prestige Consumer misses Q1 revenue estimates, to acquire Pillar5 Pharma - MarketScreener

Prestige Consumer Healthcare's Fiscal 2026 Q1 Earnings: A Strategic Masterclass in Brand Diversification and Operational Excellence - AInvest

Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results - GlobeNewswire

Prestige Healthcare Reports Mixed Q1 Results, Makes Strategic Eye Care Supplier Acquisition - Stock Titan

Stay Ahead of the Game With Prestige Consumer Healthcare (PBH) Q1 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance

Does Prestige Consumer Healthcare Inc. fit your quant trading modelPredictive AI Engine for Smart Investing - Newser

Using Python tools to backtest Prestige Consumer Healthcare Inc. strategiesImmediate Entry Point Prediction Strategy - Newser

Prestige Consumer Healthcare Inc. Flashes Rebound Signal in Oversold ConditionStrong Buy With Technical Confidence Supported - beatles.ru

Insights Ahead: Prestige Consumer's Quarterly Earnings - 富途牛牛

TheraTears® Unveils "It's a Science" Marketing Campaign - Yahoo Finance

Applying sector rotation models to Prestige Consumer Healthcare Inc.Chart-Based Entry Confirmation for Beginners - Newser

Why Prestige Consumer Healthcare Inc. stock attracts strong analyst attentionHigh Yield Signals with Entry Timing - Newser

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Price Is Out Of Tune With Earnings - simplywall.st

Applying Wyckoff theory to Prestige Consumer Healthcare Inc. stockWeekly High Conviction Trade Setup Analysis - Newser

Resistance Break Could Fuel Prestige Consumer Healthcare Inc. RallyOptimized Watchlist With Daily Adjustments Launched - metal.it

What is Prestige Consumer Healthcare Inc. company’s growth strategyRapid market gains - Jammu Links News

Detecting support and resistance levels for Prestige Consumer Healthcare Inc.Smart Risk Strategy with Entry Optimization - Newser

How many analysts rate Prestige Consumer Healthcare Inc. as a “Buy”Maximize gains with timely market signals - Jammu Links News

What are Prestige Consumer Healthcare Inc. company’s key revenue driversMaximize your returns with smart trade entries - Jammu Links News

What catalysts could drive Prestige Consumer Healthcare Inc. stock higher in 2025 - Jammu Links News

What makes Prestige Consumer Healthcare Inc. stock price move sharplyCapitalize on market shifts before others do - Jammu Links News

Prestige Consumer Healthcare Inc (PBH) 재무 분석

매출

순이익

현금흐름

주당 순 이익

PBH과 유사한 종목